By Mill Chart
Last update: Apr 29, 2024
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Ticker | Change | Comment |
---|---|---|
CAUD | 107.0% | Investors witnessed a remarkable 107.0% rise in COLLECTIVE AUDIENCE INC's (NASDAQ:CAUD) shares, which climbed to $0.81 during Monday's session. In the last month the stock lost 37.7%. |
DCPH | 72.12% | DECIPHERA PHARMACEUTICALS IN's (NASDAQ:DCPH) shares rose 72.12% to $25.21 during Monday's session. Today NASDAQ:DCPH is releasing earnings. A press release (DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders) was released earlier today. |
CLDI | 59.99% | CALIDI BIOTHERAPEUTICS INC (NYSEARCA:CLDI) witnessed a notable 59.99% uptick in its shares, reaching $0.26 during Monday's session. The stock is trading 71.56% lower than a month ago. |
HWH | 38.19% | HWH INTERNATIONAL INC (NASDAQ:HWH) witnessed a notable 38.19% uptick in its shares, reaching $2.52 during Monday's session. In the last month the stock gained 91.58%. |
SINT | 36.88% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares soared 36.88% to $0.06 during Monday's session. In the last 3 months the stock lost 86.52%. |
AGBAW | 31.53% | In an impressive move, AGBA ACQUISITION LTD -CW24's (NASDAQ:AGBAW) shares recorded a 31.53% increase, closing at $0.2 during Monday's session. In the last month the stock gained 843.0%. |
MULN | 28.83% | With a 28.83% surge, MULLEN AUTOMOTIVE INC's (NASDAQ:MULN) stock price reached $4.07 during Monday's session, signaling positive momentum. Earlier today the company had a press release: California Issues HVIP Approval, Granting Mullen’s Class 3 EV Trucks a $45,000 Cash Voucher Per Vehicle Sold. |
PHG | 28.81% | KONINKLIJKE PHILIPS NVR- NY's (NYSE:PHG) stock price is advancing with 28.81% to a price of $27.14. KONINKLIJKE PHILIPS NVR- NY released earnings Yesterday. |
CSSE | 28.08% | CHICKEN SOUP FOR THE SOUL EN's (NASDAQ:CSSE) stock price increased by 28.08% to $0.31. The stock is trading 54.6% higher than a month ago. |
BTOG | 27.41% | BIT ORIGIN LTD's (NASDAQ:BTOG) shares rose 27.41% to $4.23. In the last 3 months the share price dropped with 27.53%. |
To see the full list of top gainers you can use our top gainers page.
Ticker | Change | Comment |
---|---|---|
ANVS | -55.04% | During Monday's session, ANNOVIS BIO's (NYSE:ANVS) shares took a tumble, falling 55.04% to $8.1. Earlier today the company had a press release: Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease. |
SWVLW | -29.41% | There was a notable decline in PIVOTAL HOLDINGS CORP -CW27's (NASDAQ:SWVLW) shares, as they dropped 29.41% to $0.01 during Monday's session. In the last 3 months the share price increased with 57.73%. |
ATXI | -21.94% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price encountered a 21.94% decline, reaching $4.84 during Monday's session. A press release (Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds) was released earlier today. |
IONM | -19.46% | Investors witnessed a 19.46% decrease in ASSURE HOLDINGS CORP's (NASDAQ:IONM) stock price, which closed at $0.56 during Monday's session. In the last month the share price increased with 42.07%. |
CJJD | -19.08% | Investors witnessed a 19.08% drop in CHINA JO-JO DRUGSTORES HOLDI's (NASDAQ:CJJD) stock price, which closed at $2.29 during Monday's session. Shareholders saw the stock price going 22.44% lower in the past 3 months. |
TCJH | -17.97% | TOP KINGWIN LTD-A's (NASDAQ:TCJH) shares fell 17.97% to $0.73. Shareholders saw the stock price going 42.01% lower in the past month. |
RWODR | -17.5% | Investors witnessed a 17.5% drop in REDWOODS ACQUISITION-RIGHTS's (NASDAQ:RWODR) stock price, which closed at $0.23 during Monday's session. Shareholders saw the stock price going 75.0% higher in the past 3 months. |
ISUN | -16.67% | There was a notable decline in ISUN INC's (NASDAQ:ISUN) shares, as they dropped 16.67% to $0.14 during Monday's session. In the last month the share price dropped with 32.8%. |
FTEL | -16.0% | FITELL CORP's (NASDAQ:FTEL) shares fell 16.0% to $6.72. In the last 3 months the share price increased with 183.0%. |
SLS | -15.76% | There was a downturn in SELLAS LIFE SCIENCES GROUP I's (NASDAQ:SLS) shares, as they experienced a 15.76% decline, closing at $1.23 during Monday's session. The stock is trading 44.55% higher than a month ago. |
Our top losers page will show you the full list.
SELLAS LIFE SCIENCES GROUP I
NASDAQ:SLS (5/17/2024, 7:26:41 PM)
After market: 1.48 +0.02 (+1.37%)1.46
-0.01 (-0.68%)
SLS stock results show that SELLAS Life Sciences Gr missed analyst estimates for earnings per share the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SELLAS Life Sciences Gr (NASDAQ:SLS) just reported results for the first quarte...
- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML)...
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant...
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
These stocks are gapping in today's session
– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Patients...
SLS stock results show that SELLAS Life Sciences Gr missed analyst estimates for earnings per share the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SELLAS Life Sciences Gr (NASDAQ:SLS) just reported results for the fourth quart...
Announced Phase 2a study of SLS009 in r/r AML Showing 50% Response Rate in the Selected Optimal Dose of 30 mg BIW Exceeding the Targeted 20% and 100%...
/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced it...
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April -